En caso de que el consumidor sufra efectos adversos graves o pérdida de conciencia

debe llamarse inmediatamente a los servicios de urgencias sanitarias.

Puntos clave

El uso de NSP resulta incompatible cuando:

ƒ Se toma en combinación con alcohol u otras drogas, en particular los

estimulantes como la metanfetamina cristalina o el éxtasis.

ƒ Se conduce o se maneja maquinaria pesada.

ƒ Se requiere juicio o la coordinación motora

ƒ La persona consumidora está sola.

ƒ La persona tiene un problema de salud mental.

10. RESEÑAS BIBLIOGRÁFICAS  812'&1HZSV\FKRDFWLYHVXEVWDQFHV8QLWHG1DWLRQV2IÀFHRQ'UXJVDQG Crime.  (0&''$6\QWKHWLF&DQQDELQRLGVDQG¶6SLFH·'UXJ3URÀOH(XURSHDQ0RQLWRULQJ &HQWUHIRU'UXJVDQG'UXJ$GGLFWLRQ$YDLODEOHIURPKWWSZZZHPFGGDHXURSDHX SXEOLFDWLRQVGUXJSURÀOHVV\QWKHWLFFDQQDELQRLGV

(3) ZIMMERMANN, US. et al. (2009). Withdrawal phenomena and dependence syndrome DIWHU WKH FRQVXPSWLRQ RI ¶6SLFH *ROG· 'WVFK$U]WHEO ,QW  -XO  ² $YDLODEOHIURPGRLDU]WHEO

(4) ATWOOD BK, HUFMAN J, STRAIKER A, MACKIE K. (2010). JWH018, a common FRQVWLWXHQWRI¶6SLFH·KHUEDOEOHQGVLVDSRWHQWDQGHIÀFDFLRXVFDQQDELQRLG&%UHFHSWRU DJRQLVW%U-3KDUPDFRO²

 %$80$11 0+ $ZDVK LQ D VHD RI¶EDWK VDOWV· LPSOLFDWLRQV IRU ELRPHGLFDO UHVHDUFKDQGSXEOLFKHDOWK$GGLFWLRQ

(6) NIDA (2016). Las catinonas sintéticas («sales de baño»). Drugfacts, enero de 2016. National Institute on Drug Abuse.

 812'&  0pWRGRV UHFRPHQGDGRV SDUD OD  LGHQWLÀFDFLyQ \ HO DQiOLVLV GH ODV FDWLQRQDVVLQWpWLFDVHQORVPDWHULDOHVLQFDXWDGRV2ÀFLQDGHODV1DFLRQHV8QLGDVFRQWUD la Droga y el Delito Nueva York

 ',&.'7255$1&(&0L[0DJGUXJVVXUYH\0L[0DJ  :,1672&.$0,7&+(621/0$56'(1-0HSKHGURQHVWLOODYDLODEOHDQG

WZLFHWKHSULFH/DQFHW

(10) IDAYU, N.F., et al.(2011). Antidepressant-like effect of mitragy¬nine isolated from 0LWUDJ\QDVSHFLRVD.RUWKLQPLFHPRGHORIGHSUHVVLRQ3K\WRPHGLFLQH² (11) OBSERVATORIO EUROPEO DE LAS DROGAS Y LAS TOXICOMANÍAS y Europol

,QIRUPHVREUHORVPHUFDGRVGHGURJDVHQOD8(9LVLyQGHFRQMXQWRHVWUDWpJLFD SXEOLFDFLRQHVFRQMXQWDVGHO(0&''$(XURSRO2ÀFLQDGH3XEOLFDFLRQHVGHOD8QLyQ Europea, Luxemburgo.

(12) OEDT (2016). Informe Europeo sobre Drogas 2016. Tendencias y novedades. Observatorio Europeo de las Drogas y las Toxicomanías.

812'&*OREDO6PDUW8SGDWH9ROXPHQPDU]R2ÀFLQDGHODV1DFLRQHV Unidas Contra la Droga y el Delito.

:,1672&.$5%$55$770-6\QWKHWLFFDQQDELV$FRPSDULVRQRISDWWHUQV RIXVHDQGHIIHFWSURÀOHZLWKQDWXUDOFDQQDELVLQDODUJHJOREDOVDPSOH'UXJ$OFRKRO 'HSHQG

(15) ESPERT, R., PÉREZ, J., GADEA, M., OLTRA-CUCARELLA, J., ALIÑO, M. (2015). Drogas OHJDOHVHPHUJHQWHVPDULKXDQDVLQWpWLFDNUDWRPVDOYLDGLYLQRUXPPHWR[HWDPLQD\ORV GHULYDGRVGHODSLSHUD]LQD5HYLVWD(VSDxRODGH'URJRGHSHQGHQFLDV (16) KANE, C. (2011). bit.ly/sIlFaY. Pediatrics, online November 7.

*5(**5$5$:/660%HKDYLRUDOSKDUPDFRORJ\RIGHVLJQHUFDWKLQRQHVD UHYLHZRIWKHSUHFOLQLFDOOLWHUDWXUH/LIH6FLSiJVD

(18) ACDM (2011). Consideration of the Novel Psychoactive Substances (‘Legal Highs’). YLVRU\&RXQFLORQWKH0LVXVHRI'UXJV$YDLODEOHIURPKWWSVZZZJRYXNJRYHUQPHQW XSORDGVV\VWHPXSORDGVDWWDFKPHQWBGDWDÀOHDFPGQSVSGI

9$/(17(0-HWDO.KDWDQGV\QWKHWLFFDWKLQRQHVDUHYLHZ$UFK7R[LFRO 

(20) NIDA (2016). Las catinonas sintéticas (“sales de baño”). Drugfacts, enero de 2016. National Institute on Drug Abuse.

%85,//2387=(*HWDO'URJDVHPHUJHQWHV,ODV´VPDUWGUXJVµ$Q6LVW 6DQLW1DYDU9RO1žPD\RDJRVWR

(22) FERRARI, L. (2016). Nuevas drogas de diseño psicoactivas (NPS). Estado actual del FRQRFLPLHQWR&LHQFLDH,QYHVWLJDFLyQ7RPRQž

(23) SCHIFANO, F., et al. (2011). Psychonaut Web Mapping y ReD Net Research Groups, ´0HSKHGURQHPHWK\OPHWKFDWKLQRQH¶PHRZPHRZ·FKHPLFDOSKDUPDFRORJLFDODQG FOLQLFDOLVVXHVµ3V\FKRSKDUPDFRORJ\%HUOSiJVD

.8(33(569% &22.( &7  ,1%20H UHODWHG GHDWK LQ$XVWUDOLD$ FDVH UHSRUW)RUHQVLF6FL,QWH

(25) ALATRASH, G., MAJHAIL, N.S. PILE, J.C. (2006). Rhabdomyolysis after ingestion of “Foxy,” a hallucinogenic tryptamine derivative. Mayo Clinic Proceedings, 2006, 81 (4), 550-1.

(26) EINOSUKE, T., TOORU, K., MUNEHIRO, K., HITOSHI, T., KATSUYA, H. (2006). A fatal poisoning with 5-methoxy-N, N-diisopropyltryptamine, Foxy. Forensic Science ,QWHUQDWLRQDO²

(27) OMS (2015). Comité de Expertos en Farmacodependencia, Thirtysixthreport. Serie de ,QIRUPHV7pFQLFRVGHOD2UJDQL]DFLyQ0XQGLDOGHOD6DOXGSiJV (28) UNODC (2013). The challenge of new psychoactive substances. A Report from the

*OREDO60$573URJUDPPH0DUFK8QLWHG1DWLRQV2IÀFHRQ'UXJVDQG&ULPH (29) KRONSTRAND, R., ROMAN, M., THELANDER, G., ERIKSSON, A. (2011). Unintentional

fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend .U\SWRQ-RXUQDORI$QDOLW\FDO7R[LFRORJ\²

92+5$56(()(/'$&$175(//)/&ODUN5)6DOYLDGLYLQRUXPH[SRVXUHV reported to a statewide poison control sys¬tem over 10 years. TheJournal of Emergency 0HGLFLQH²

(31) BAGGOTT, M., EROWID, E., EROWID, F. (2004). A survey of Salvia divinorum users. (URZLG([WUDFWV² %$48(52$HWDO&RQVXPRGHNURNRGLOSRUYtDRUDOHQ(VSDxDDSURSyVLWR GHXQFDVR5HYLVWD$GLFFLRQHVYHUVLyQRQOLQH'LVSRQLEOHHQKWWSZZZDGLFFLRQHVHV index.php/adicciones/article/view/828. 0$7,8.'0.URNRGLO$0RQVWURXV'UXJZLWK'HDGO\&RQVHTXHQFHV-RXUQDO of Addictive Disorders, 1-14. '(%25$+/$'(5HG'UXJ0LVXVH)LQGLQJVIURPWKH&ULPH6XUYH\ IRU(QJODQGDQG:DOHVQGHG/RQGRQ+RPH2IÀFH */2%$/'58*6859(<$YDLODEOH)URPKWWSZZZJOREDOGUXJVXUYH\FRPWKH JOREDOGUXJVXUYH\ÀQGLQJV

(36) ABDULRAHIM D & BOWDEN-JONES O, on behalf of the NEPTUNE Expert Group (2015). Guidance on the Management of Acute and Chronic Harms of Club Drugs DQG 1RYHO 3V\FKRDFWLYH 6XEVWDQFHV /RQGRQ 1RYHO 3V\FKRDFWLYH 7UHDWPHQW 8. 1HWZRUN1(3781($YDLODEOHIURPKWWSQHSWXQHFOLQLFDOJXLGDQFHFRXNZSFRQWHQW uploads/2015/03/NEPTUNE-Guidance-March-2015.pdf

(37) LANCASTER K, HUGHES, CE. SPICER, B. MATTHEW-SIMMONS, FR. DILLON, P. (2011). ,OOLFLWGUXJVDQGWKHPHGLD0RGHOVRIPHGLDHIIHFWVIRUXVHLQGUXJSROLF\UHVHDUFK'UXJ DQG$OFRKRO5HYLHZ-XO

81'2&:RUOG'UXJ5HSRUW8QLWHG1DWLRQV2IÀFHRQ'UXJVDQG&ULPH KWWSVZZZXQRGFRUJGRFZGU:25/'B'58*B5(3257BBZHESGI 812'&:RUOG'UXJ5HSRUW8QLWHG1DWLRQV2IÀFHRQ'UXJVDQG&ULPH

$YDLODEOH IURP KWWSVZZZXQRGFRUJXQRGFVHFXUHGZGUZGU:RUOGB'UXJB Report_2013.pdf

(0&''$  (XURSHDQ 'UXJ 5HSRUW 7UHQGV DQG 'HYHORSPHQWV$YDLODEOH IURPKWWSZZZHPFGGDHXURSDHXSXEOLFDWLRQVHGUWUHQGV GHYHORSPHQWV 8.+RPH2IÀFHDQGWKH5W+RQRXUDEOH1RUPDQ%DNHU1HZ3V\FKRDFWLYH6XEVWDQFHV

5HYLHZ 5HSRUW RI WKH ([SHUW 3DQHO $YDLODEOH IURP KWWSVZZZJRYXNJRYHUQPHQW XSORDGVV\VWHPXSORDGVDWWDFKPHQWBGDWDÀOH136H[SHUW5HYLHZ3DQHO5HSRUWSGI (8523($1&200,66,21)ODVK(XUREDURPHWHU<RXQJ3HRSOHDQG'UXJV

$YDLODEOHIURPKWWSHFHXURSDHXSXEOLFBRSLQLRQÁDVKÁBBHQSGI

(43) EMCDDA-Europol (2013). Annual Report on the implementation of Council Decision -+$$YDLODEOHIURPKWWSZZZHPFGGDHXURSDHXDWWDFKHPHQWVFIPDWWBB EN_TDAN14001ENN.pdf

(0&''$ 7HFKQLFDO 5HSRUW7KH ,QWHUQHW DQG 'UXJ 0DUNHWV$YDLODEOH IURP KWWSZZZHPFGGDHXURSDHXV\VWHPILOHVSXEOLFDWLRQV,QWHUQHWDQG drug%20markets%20study.pdf

(45) PUBLIC HEALTH ENGLAND (2015). Adult Substance Misuse Statistics from the 1DWLRQDO'UXJ7UHDWPHQW0RQLWRULQJ6\VWHP1'706$SULOWR0DUFK (London, 2015).

)(,/',1* $ 6,1*/(721 1 5RDGPDSV WR UHJXODWLRQ QHZ SV\FKRDFWLYH substances (NPS).Beckley Park, Oxford OX3 9SY. United Kingdom.

(47) LING, L. et al. (2001). Poisoning with the recreational drug paramethoxyamphetamine ´GHDWKµ0HGLFDO-RXUQDORI$XVWUDOLD

(48) ORSOLINI, L., FRANCESCONI, G. PAPANTI, D., GIORGETTI, A., SCHIFANO, F. (2015). 3URÀOLQJ RQOLQH UHFUHDWLRQDOSUHVFULSWLRQ GUXJV· FXVWRPHUV DQG RYHUYLHZ RI GUXJ YHQGLQJYLUWXDOPDUNHWSODFHV+XPDQ3V\FKRSKDUPDFRORJ\&OLQLFDODQG([SHULPHQWDO -XO

'58*6&23(  'RZQ D 6WRQ\ 5RDG 7KH  'UXJ6FRSH 6WUHHW

'UXJ 6XUYH\  $YDLODEOH IURPKWWSZZZVIDGRUJXNXVHUÀOHVÀOHV

DownAStonyRoadDrugTrendsSurvey2014.pdf

(50) HONDEBRINK L, NUGTEREN-VAN LONKHUYZEN JJ, VAN DER GOUWE D, %5817700RQLWRULQJQHZSV\FKRDFWLYHVXEVWDQFHV136LQ7KH1HWKHUODQGV Data from the drug market and the Poisons Information Centre. Drug and alcohol GHSHQGHQFH)HE

(51) DINES, AM. et al. (2015). Acute recreational drug and new psychoactive substance WR[LFLW\ LQ (XURSH  PRQWKV GDWD FROOHFWLRQ IURP WKH (XURSHDQ 'UXJ (PHUJHQFLHV 1HWZRUN(XUR'(1&OLQLFDO7R[LFRORJ\2FW

812'&*/2%$/60$5783'$7(9ROXPHQVHSWLHPEUH2ÀFLQDGH las Naciones Unidas Contra la Droga y el Delito.